ResMed Inc. (RMD) Financials

RMD Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 8.8 billion 2.3 billion
Dec. 31, 2025 8.5 billion 2.2 billion
Sept. 30, 2025 8.3 billion 2.2 billion
June 30, 2025 8.2 billion 2.2 billion

RMD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 520.5 million 26.8 million
Dec. 31, 2025 311.2 million 28.9 million
Sept. 30, 2025 414.4 million 21.2 million
June 30, 2025 508.2 million 24.8 million

RMD Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 398.7 million
Dec. 31, 2025 392.6 million
Sept. 30, 2025 348.5 million
June 30, 2025 379.7 million

RMD Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.7 billion 404.2 million 149.8 million
Dec. 31, 2025 1.4 billion 558.1 million 154.1 million
Sept. 30, 2025 1.4 billion 408.7 million 177.8 million
June 30, 2025 1.2 billion 658.4 million 183.5 million

RMD Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 147.0 million
Dec. 31, 2025 147.0 million
Sept. 30, 2025 147.0 million
June 30, 2025 147.0 million

RMD Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 33.7 million 94.3 million 279.8 million -
Dec. 31, 2025 28.5 million 91.0 million 278.4 million -
Sept. 30, 2025 43.0 million 87.3 million 259.2 million -
June 30, 2025 30.6 million 86.4 million 265.1 million -

RMD Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.4 billion 540.4 million
Dec. 31, 2025 1.4 billion 538.1 million
Sept. 30, 2025 1.3 billion 514.8 million
June 30, 2025 1.3 billion 527.9 million

RMD Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RMD

List: Contenders

Price: $196.04

52 week price:
180.27
293.81

Dividend Yield: 1.29%

5-year range yield:
0.61%
1.40%

Forward Dividend Yield: 1.24%

Payout Ratio: 30.59%

Payout Ratio Range:
-72.31%
523.30%

Dividend Per Share: 2.40 USD

Earnings Per Share: 10.37 USD

P/E Ratio: 20.22

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 1.2 million

Ebitda: 178.5 million

Market Capitalization: 27.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 15

DGR3: 8.09%

DGR5: 6.39%

DGR10: 6.63%

Links: